WATTS RYAN J. (President and CEO) received a stock award from DENALI THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2026ACC: 0001724310-26-000001
DirectorOfficer· President and CEO
Since Aug 2018
+315.84K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
315.84K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+78.96K
Price / share
—
Trade value
—
% of position
31.2%
1/3/2026
253.07K→332.03K
Total
Net shares
+78.96K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2026 | A · Award | +78.96K | — | — | 31.2% | 253.07K | 332.03K |
| Total | +78.96K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
236.88K shares
Shares
+236.88K
Strike price
16.27
Held after
236.88K
Exercisable
—
1/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock236.88K shares | 1/3/2026 | A · Award | +236.88K | 16.27 | — | 236.88K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.15M
Total
2.15M indirect2.15M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.15M | Indirect |
| Total | 2.15M | 2.15M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported